GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Upstream Bio Inc (NAS:UPB) » Definitions » Total Operating Expense

UPB (Upstream Bio) Total Operating Expense : $97.06 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Upstream Bio Total Operating Expense?

Upstream Bio's Total Operating Expense for the three months ended in Mar. 2025 was $32.58 Mil. Upstream Bio's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was $97.06 Mil.

Upstream Bio Total Operating Expense Historical Data

The historical data trend for Upstream Bio's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Upstream Bio Total Operating Expense Chart

Upstream Bio Annual Data
Trend Dec22 Dec23 Dec24
Total Operating Expense
25.12 42.49 80.13

Upstream Bio Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Operating Expense Get a 7-Day Free Trial 15.65 18.05 19.50 26.93 32.58

Upstream Bio Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $97.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Upstream Bio Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Upstream Bio's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Upstream Bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Upstream Bio Inc (NAS:UPB) » Definitions » Total Operating Expense
Comparable Companies
URGN DNA NWBO RGNX PGEN EYPT TRML MNMD CGEM OMER VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
890 Winter Street, Suite 200, Waltham, MA, USA, 02451
Website
https://www.upstreambio.com
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.